Legal Representation
Attorney
Cara M. Kearney
USPTO Deadlines
Next Deadline
3059 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20040615)
Due Date
June 15, 2034
Grace Period Ends
December 15, 2034
Application History
44 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Mar 18, 2025 | EWAF | I | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | Loading... |
| Mar 18, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 18, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 18, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 21, 2024 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jun 21, 2024 | RNL2 | Q | REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS) | Loading... |
| Jun 21, 2024 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Jun 21, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Apr 11, 2024 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Apr 11, 2024 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Apr 11, 2024 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 21, 2024 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Jun 15, 2023 | REM2 | E | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | Loading... |
| Nov 9, 2018 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Nov 9, 2018 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Mar 8, 2016 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 8, 2016 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Oct 6, 2014 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Oct 6, 2014 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 28, 2014 | NA89 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | Loading... |
| Jun 28, 2014 | RNL1 | Q | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | Loading... |
| Jun 28, 2014 | 89AG | O | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | Loading... |
| Jun 27, 2014 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jun 12, 2014 | E89R | I | TEAS SECTION 8 & 9 RECEIVED | Loading... |
| Dec 4, 2010 | C15A | O | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Dec 4, 2010 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Nov 17, 2010 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jun 15, 2004 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Mar 23, 2004 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 3, 2004 | NPUB | O | NOTICE OF PUBLICATION | Loading... |
| Jan 26, 2004 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 9, 2003 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jun 23, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 8, 2003 | CFIT | O | CASE FILE IN TICRS | Loading... |
| Jun 23, 2003 | I | PAPER RECEIVED | Loading... | |
| Apr 14, 2003 | CNSL | S | LETTER OF SUSPENSION MAILED | Loading... |
| Jan 17, 2003 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 17, 2003 | I | PAPER RECEIVED | Loading... | |
| Nov 4, 2002 | CNFR | O | FINAL REFUSAL MAILED | Loading... |
| Sep 6, 2002 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jun 24, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jun 27, 2002 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 21, 2001 | CNRT | F | NON-FINAL ACTION MAILED | Loading... |
| Dec 12, 2001 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Detailed Classifications
Class 005
pharmaceuticals used in treatment of [cardiovascular,] autoimmune, and neurological diseases, cancer[, and xenographic transplants]
First Use Anywhere:
19960300
First Use in Commerce:
19960300
Class 042
research and development of technologies for the treatment of [cardiovascular,] autoimmune, neurological diseases, and cancer [and research and development of technologies in the field of xenographic transplants]
First Use Anywhere:
19920400
First Use in Commerce:
19920400
Classification
International Classes
005
042